InvestorsHub Logo
Followers 17
Posts 10839
Boards Moderated 0
Alias Born 03/11/2017

Re: None

Friday, 12/08/2017 7:58:40 PM

Friday, December 08, 2017 7:58:40 PM

Post# of 44784
Thesaud--Mesoblast Cannot Even Come Close To This !


Pluristem Gets Accelerated Approval Pathways in Top 3 Healthcare Markets – U.S., Europe, Japan.



https://www.bioinformant.com/pluristem-accelerated-approval-u-s-europe-japan/